Literature DB >> 2994459

Lymphadenopathy morphologically consistent with Hodgkin's disease associated with Epstein-Barr virus infection.

S Poppema, G van Imhoff, R Torensma, J Smit.   

Abstract

This case report describes a case of chronic Epstein-Barr virus infection resulting in lymphadenopathy morphologically indistinguishable from Hodgkin's disease. Morphologic, immunologic, and virologic studies could be performed on three consecutive lymph nodes. For the first time in the literature, Epstein-Barr Nuclear Antigen (EBNA) could be demonstrated in the nuclei of Sternberg-Reed cells.

Entities:  

Mesh：

Year:  1985        PMID： 2994459     DOI： 10.1093/ajcp/84.3.385

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN： 0002-9173            Impact factor:   2.493


  12 in total

1.  Absence of HLA class I expression by Reed-Sternberg cells.

Authors:  S Poppema; L Visser
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

2.  Epstein-Barr viral DNA in tissues of Hodgkin's disease.

Authors:  L M Weiss; J G Strickler; R A Warnke; D T Purtilo; J Sklar
Journal:  Am J Pathol       Date:  1987-10       Impact factor: 4.307

3.  Atypical immunoproliferative disorders: when of age?

Authors:  G Frizzera
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

Review 4.  Detection and characterization of Epstein-Barr virus in clinical specimens.

Authors:  R F Ambinder; R B Mann
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

5.  Quantity of nuclear DNA in malignancies and benign lymphadenopathies associated with Epstein-Barr virus.

Authors:  T Lehtinen; M Lehtinen; R Aine; K Dammert; P Kulomaa; M Alavaikko; P Leinikki
Journal:  J Clin Pathol       Date:  1989-07       Impact factor: 3.411

6.  Expression of B-cell antigens by Hodgkin's and Reed-Sternberg cells.

Authors:  C Schmid; L Pan; T Diss; P G Isaacson
Journal:  Am J Pathol       Date:  1991-10       Impact factor: 4.307

7.  Detection of Epstein-Barr genome in the lymph nodes of Hodgkin's disease.

Authors:  C Bellas; F Mampaso; G Fraile; A Molina; T Bricio; C Cuesta
Journal:  Postgrad Med J       Date:  1993-12       Impact factor: 2.401

Review 8.  Epstein-Barr virus: more than 50 years old and still providing surprises.

Authors:  Lawrence S Young; Lee Fah Yap; Paul G Murray
Journal:  Nat Rev Cancer       Date:  2016-09-30       Impact factor: 60.716

Review 9.  Targeting the signaling in Epstein-Barr virus-associated diseases: mechanism, regulation, and clinical study.

Authors:  Ya Cao; Longlong Xie; Feng Shi; Min Tang; Yueshuo Li; Jianmin Hu; Lin Zhao; Luqing Zhao; Xinfang Yu; Xiangjian Luo; Weihua Liao; Ann M Bode
Journal:  Signal Transduct Target Ther       Date:  2021-01-12

10.  Immunization With Fc-Based Recombinant Epstein-Barr Virus gp350 Elicits Potent Neutralizing Humoral Immune Response in a BALB/c Mice Model.

Authors:  Bingchun Zhao; Xiao Zhang; Claude Krummenacher; Shuo Song; Ling Gao; Haojiong Zhang; Miao Xu; Lin Feng; Qisheng Feng; Musheng Zeng; Yuting Xu; Yixin Zeng
Journal:  Front Immunol       Date:  2018-05-01       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.